| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.098 | 0.7 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.074 | 0.8 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |